Eton Pharmaceuticals (ETON) Interest Expenses (2017 - 2025)

Eton Pharmaceuticals (ETON) has 9 years of Interest Expenses data on file, last reported at $930000.0 in Q4 2025.

• For the quarter ending Q4 2025, Interest Expenses rose 564.29% year-over-year to $930000.0; the trailing twelve-month figure through Dec 2025 stood at $1.9 million (up 34.8% YoY), and the FY2025 full-year result was $68.3 million, up 33.15% from the prior year.
• Interest Expenses declined to $930000.0 in Q4 2025, from $97.8 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $97.8 million in Q3 2025 to a low of $140000.0 in Q4 2024.
• A 5-year average of $11.5 million and a median of $840500.0 in 2023 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses plunged 94.07% in 2021 and soared 8423.03% in 2025, its largest moves.
• Tracing ETON's Interest Expenses over 5 years: stood at $439000.0 in 2021, then retreated by 6.61% to $410000.0 in 2022, then rose by 2.93% to $422000.0 in 2023, then tumbled by 66.82% to $140000.0 in 2024, then jumped by 564.29% to $930000.0 in 2025.
• Business Quant data shows ETON's Interest Expenses at $930000.0 in Q4 2025, $97.8 million in Q3 2025, and $54.0 million in Q2 2025.